ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND BEYOND
- Funded by Biomedical Advanced Research and Development Authority (BARDA)
- Total publications:0 publications
Grant number: 75A50123C00013
Grant search
Key facts
Disease
COVID-19Start & end year
20232026Known Financial Commitments (USD)
$33,771,970Funder
Biomedical Advanced Research and Development Authority (BARDA)Research Location
United States of AmericaLead Research Institution
APTITUDE MEDICAL SYSTEMS INCResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
DiagnosticsSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND BEYOND